Alpha Centric Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History

Alpha Centric Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Mar 09, 2022	SELL	$43.34 - $65.91 $34,672 - $52,728	-800 Closed	0 $0
Q4 2020 Mar 11, 2022	BUY	$23.3 - $59.57 $8,155 - $20,849	350 Added 77.78%	800 $44,000
Q3 2020 Mar 11, 2022	SELL	$20.5 - $28.59 $1,025 - $1,429	-50 Reduced 10.0%	450 $10,000
Q2 2020 Mar 11, 2022	BUY	$13.32 - $22.61 $6,660 - $11,305	500 New	500 $10,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.